About 20% of those screened will fail the screening, so about 21 will join the trial, which is far more than in previous months.
This figure is likely to increase in future months, as sites get more used to the trial, and they start to see some improvements in patients on the trial.
Ann: Clinical Trial Update, page-12
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable